Targeting VDAC: A potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease
-
Published:2024-07
Issue:
Volume:1835
Page:148920
-
ISSN:0006-8993
-
Container-title:Brain Research
-
language:en
-
Short-container-title:Brain Research
Author:
Yang Yaqian,
Jia Xiaotao,
Yang Xinmao,
Wang JieORCID,
Fang Yan,
Ying Xiaoping,
Zhang Meiqian,
Wei Jing,
Pan YanfangORCID
Reference115 articles.
1. Adebayo, M., Singh, S., Singh, A.P., & Dasgupta, S., 2021. Mitochondrial fusion and fission: The fine-tune balance for cellular homeostasis. FASEB J. 35(6), e21620-e21642. https://doi.org/10.1096/fj.202100067R.
2. Voltage-dependent anion channels (VDAC) in the plasma membrane play a critical role in apoptosis in differentiated hippocampal neurons but not in neural stem cells;Akanda;Cell Cycle,2008
3. Therapeutic potential of targeting mitochondria for alzheimer's disease treatment;Atlante;J. Clin. Med.,2022
4. Dysfunction of mitochondria in alzheimer's disease: ANT and VDAC interact with toxic proteins and aid to determine the fate of brain cells;Atlante;Int. J. Mol. Sci.,2022
5. Mitochondria-mediated moderation of apoptosis by EGCG in cytotoxic neuronal cells induced by lead (Pb) and amyloid peptides;Ayyalasomayajula;Biol. Trace Elem. Res.,2022